Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BLOMSTER APOTEKET ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6%   Bankruptcy risk   2.4% 3.0% 3.1% 2.7% 2.5% 2.6% 16.6% 16.2%   Credit score (0-100)   65 58 56 59 62 61 11 11   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,282 1,118 1,033 1,044 911 848 0.0 0.0   EBITDA   244 20.0 4.0 93.6 29.7 18.8 0.0 0.0   EBIT   223 -15.8 -27.2 63.8 -0.1 1.5 0.0 0.0   Pre-tax profit (PTP)   223.3 -16.4 -32.5 61.9 -3.9 1.9 0.0 0.0   Net earnings   189.0 -14.8 -27.7 46.9 -8.7 2.4 0.0 0.0   Pre-tax profit without non-rec. items   223 -16.4 -32.5 61.9 -3.9 1.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   141 106 74.5 44.7 14.9 20.0 0.0 0.0   Shareholders equity total   400 385 358 404 396 398 148 148   Interest-bearing liabilities   0.5 0.5 0.5 0.5 0.5 0.5 0.0 0.0   Balance sheet total (assets)   654 709 635 600 599 573 148 148   Net Debt   -201 -350 -293 -115 -189 -174 -148 -148     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,282 1,118 1,033 1,044 911 848 0.0 0.0   Gross profit growth   26.9% -12.8% -7.6% 1.0% -12.7% -6.8% -100.0% 0.0%   Employees   4 3 4 4 0 4 0 0   Employee growth %   100.0% -25.0% 33.3% 0.0% -100.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   654 709 635 600 599 573 148 148   Balance sheet change%   59.7% 8.4% -10.5% -5.4% -0.3% -4.3% -74.1% 0.0%   Added value   244.2 20.0 4.0 93.6 29.7 18.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   107 -71 -63 -60 -60 -12 -20 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 -2.0 1.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   17.4% -1.4% -2.6% 6.1% -0.0% 0.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   42.0% -2.3% -4.1% 10.3% -0.0% 0.3% 0.0% 0.0%   ROI %   72.6% -4.0% -7.3% 16.7% -0.0% 0.5% 0.0% 0.0%   ROE %   61.9% -3.8% -7.5% 12.3% -2.2% 0.6% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   61.1% 54.3% 56.3% 67.4% 66.1% 69.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -82.2% -1,753.5% -7,248.5% -122.6% -636.8% -925.1% 0.0% 0.0%   Gearing %   0.1% 0.1% 0.2% 0.1% 0.1% 0.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.1% 117.3% 987.7% 364.7% 709.4% 3.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.5 1.4 1.6 1.8 1.9 2.0 0.0 0.0   Current Ratio   2.0 1.9 2.0 2.9 2.9 3.2 0.0 0.0   Cash and cash equivalent   201.2 350.7 293.9 115.3 189.6 174.1 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   261.8 279.5 283.0 360.9 380.9 378.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   61 7 1 23 0 5 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   61 7 1 23 0 5 0 0   EBIT / employee   56 -5 -7 16 0 0 0 0   Net earnings / employee   47 -5 -7 12 0 1 0 0